{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-390562","form_type":"8-K","ticker":"TEVA","cik":"0000818686","company_name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","filed_at":"2026-09-14T20:06:27+00:00","discovered_at":"2026-09-14T20:07:02.558382+00:00","generated_at":"2026-09-14T20:07:10.906088+00:00","sec_items":["8.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Teva begins trading ordinary shares on NYSE; ADS program terminated","bullets":["Effective Sept 14, 2026, Teva ordinary shares trade on NYSE under 'TEVA', replacing ADSs.","Each American depositary share exchanged for one ordinary share; ADS program terminated.","Shares continue to trade on Tel Aviv Stock Exchange under same symbol 'TEVA'.","Ticker unchanged, but security type changes from ADS to ordinary share."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-390562","json":"https://secwatch.observer/filing/0001193125-26-390562.json","markdown":"https://secwatch.observer/filing/0001193125-26-390562.md","text":"https://secwatch.observer/filing/0001193125-26-390562.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/818686/000119312526390562/0001193125-26-390562-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/818686/000119312526390562/d503082d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-09-14T20:07:10.906088+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}